Learn Derm Podcast

In the second episode of season 3, we continue our three episode series on hidradenitis suppurativa with a discussion of the pathogenesis, comorbidities, and treatment of HS. We break down the complex treatment of HS into five categories including trigger avoidance, topical therapies, systemic oral agents, biologics, and surgery.  References: Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76-90. doi:10.1016/j.jaad.2019.02.067 Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91-101. doi: